GTR 116988711
Tenders Are Invited For Immune Sera And Immunoglobulins – Medicine With The Active Substance Palivizumab
ICB — International Competitive Bid
Closes Sep 21, 2026
Europe
Tender Information
GTR Reference
116988711
Tendering Authority
Subscribe to view
Tender No
564243-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Immune Sera And Immunoglobulins – Medicine With The Active Substance Palivizumab
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Europe
Political Region
European Union
Last Date of Bid Submission
21-09-2026
Work Detail
Immune Sera And Immunoglobulins – Medicine With The Active Substance Palivizumab. The Subject Of The Order Is: Medicine With The Active Substance Palivizumab Palivizumab Is A Recombinant Humanized Monoclonal Antibody Produced By Dna Technology In Mouse Myeloma Host Cells. One 0.5 Ml Vial Contains 50 Mg Of Palivizumab The Drug Is Indicated For The Prevention Of Severe Lower Respiratory Tract Disease Requiring Hospitalization Caused By Respiratory Syncytial Virus (Rsv) In Children At High Risk Of Rsv Disease: • Children Who Were Born At 35 Weeks Of Pregnancy Or Earlier And Are Younger Than 6 Months At The Beginning Of The Rsv Season; • Children Under 2 Years Of Age Who Have Needed Treatment For Bronchopulmonary Dysplasia In The Last 6 Months; • Children Under 2 Years Of Age With Hemodynamically Significant Congenital Heart Disease
Key Value
Tender Value
352,332 - SKK
Tender Documents
Global Tender Document
d94794ed-3da8-4d32-90e8-9099dc270a4c.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.